Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$1.3M
Filings
61
Firms Hired
3
Active Period
2019–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to bivalent vaccines; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues related to 2024 Physician Fee Schedule; H.R. 946/S. 1862, Orphan Cures Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 946
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to bivalent vaccines; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues related to 2024 Physician Fee Schedule; H.R. 946/S. 1862, Orphan Cures Act
Client expense: — · Firm income: $50,000
Matched citations: S. 1862
Full-Year Continuing Appropriations and Extensions Act, 2025
2025 · first_quarter · Firm: AVENUE SOLUTIONS
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to bivalent vaccines; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease;
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1968
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to bivalent vaccines; S. 891, Bipartisan Health Care Act; H.R. 1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (PL 119-4); Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease;
Client expense: — · Firm income: $50,000
Matched citations: S. 891
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to bivalent vaccines; Expiring health extenders; H.R. 10545, American Relief Act, 2025
Client expense: — · Firm income: $50,000
Matched citations: H.R. 10545
Further Consolidated Appropriations Act, 2024
2024 · first_quarter · Firm: AVENUE SOLUTIONS
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to the commercialization of COVID-19 vaccines; Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2882
Consolidated Appropriations Act, 2024
2024 · first_quarter · Firm: AVENUE SOLUTIONS
Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to the commercialization of COVID-19 vaccines; Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Expiring healthcare extenders; H.R. 4366, the Consolidated Appropriations Act, 2024 (P.L. 118-42); H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47)
Client expense: — · Firm income: $50,000
Matched citations: H.R. 4366
Relating to a national emergency declared by the President on March 13, 2020.
2023 · first_quarter · Firm: AVENUE SOLUTIONS
Issues related to the Vaccine Injury Compensation Fund (VICF); Issues related to the commercialization of COVID-19 vaccines; H.J.Res.7, terminating the national emergency related to the COVID-19 pandemic; Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization
Client expense: — · Firm income: $50,000
Matched citations: H.J.Res.7
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
H.R. 2617, Consolidated Appropriations Act, 2023 - allowing new vaccines to be added to the Vaccine Injury Compensation Fund (VICF); Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes; Issues related to Vaccine Injury Compensation Fund (VICF); Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2617
To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes.
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
H.R. 2617, Consolidated Appropriations Act, 2023 - allowing new vaccines to be added to the Vaccine Injury Compensation Fund (VICF); Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes; Issues related to Vaccine Injury Compensation Fund (VICF); Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6007
COVID Supplemental Appropriations Act, 2022
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
H.R. 2617, Consolidated Appropriations Act, 2023 - allowing new vaccines to be added to the Vaccine Injury Compensation Fund (VICF); Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes; Issues related to Vaccine Injury Compensation Fund (VICF); Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Client expense: — · Firm income: $50,000
Matched citations: H.R. 7007
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: AVENUE SOLUTIONS
H.R. 2617, Consolidated Appropriations Act, 2023 - allowing new vaccines to be added to the Vaccine Injury Compensation Fund (VICF); Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes; Issues related to Vaccine Injury Compensation Fund (VICF); Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Client expense: — · Firm income: $50,000
Matched citations: H.R. 7667
H.R. 2617, Consolidated Appropriations Act, 2023 - allowing new vaccines to be added to the Vaccine Injury Compensation Fund (VICF); Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes; Issues related to Vaccine Injury Compensation Fund (VICF); Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Client expense: — · Firm income: $50,000
Matched citations: S. 3799
H.R. 2617, Consolidated Appropriations Act, 2023 - allowing new vaccines to be added to the Vaccine Injury Compensation Fund (VICF); Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes; Issues related to Vaccine Injury Compensation Fund (VICF); Executive Order Directing HHS to Explore Additional Actions to Lower Prescription Drug Costs
Client expense: — · Firm income: $50,000
Matched citations: S. 4348
Issues related to the implementation of the Inflation Reduction Act of 2022, PL 117-169; Issues related to the Continuing Resolution, H.R.6833; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 President's Budget; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5585
To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes.
2022 · third_quarter · Firm: AVENUE SOLUTIONS
Issues related to the implementation of the Inflation Reduction Act of 2022, PL 117-169; Issues related to the Continuing Resolution, H.R.6833; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 President's Budget; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: H.R. 6007
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
2022 · third_quarter · Firm: AVENUE SOLUTIONS
Issues related to the implementation of the Inflation Reduction Act of 2022, PL 117-169; Issues related to the Continuing Resolution, H.R.6833; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 President's Budget; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: H.R.6833
COVID Supplemental Appropriations Act, 2022
2022 · third_quarter · Firm: AVENUE SOLUTIONS
Issues related to the implementation of the Inflation Reduction Act of 2022, PL 117-169; Issues related to the Continuing Resolution, H.R.6833; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 President's Budget; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: H.R. 7007
Food and Drug Amendments of 2022
2022 · third_quarter · Firm: AVENUE SOLUTIONS
Issues related to the implementation of the Inflation Reduction Act of 2022, PL 117-169; Issues related to the Continuing Resolution, H.R.6833; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 President's Budget; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: H.R. 7667
Issues related to the implementation of the Inflation Reduction Act of 2022, PL 117-169; Issues related to the Continuing Resolution, H.R.6833; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 President's Budget; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: S. 3799
Issues related to the implementation of the Inflation Reduction Act of 2022, PL 117-169; Issues related to the Continuing Resolution, H.R.6833; Issues related to reauthorization of FDA user fee bills (H.R. 7667, Food and Drug Amendments of 2022; S. 4348, Food and Drug Administration Safety and Landmark Advancements Act of 2022 (FDSLA Act of 2022)), including accelerated approval and reimportation; Issues related to the Public Health Emergency; Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 President's Budget; H.R. 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: S. 4348
Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 Presidents Budget; HR 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: H.R. 5585
To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes.
2022 · second_quarter · Firm: AVENUE SOLUTIONS
Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 Presidents Budget; HR 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: HR 6007
COVID Supplemental Appropriations Act, 2022
2022 · second_quarter · Firm: AVENUE SOLUTIONS
Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 Presidents Budget; HR 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: H.R. 7007
Issues related to COVID-19 vaccines, manufacturing, and distribution; H.R. 7007, COVID Supplemental Appropriations Act, 2022; Consolidated Appropriations Act, 2022 (PL 117-103); S. 3799, PREVENT Pandemics Act; H.R. 5585, The Advanced Research Project Agency-Health (ARPA-H) Act; Issues related to the FY 2023 Presidents Budget; HR 6007, To amend title XVIII of the Social Security Act to provide for the expansion of coverage of vaccines under part B of the Medicare program, and for other purposes
Client expense: — · Firm income: $50,000
Matched citations: S. 3799
Source: Senate LDA